Showing results 29 to 48 of 49
< previous
next >
Issue Date | Title | Author(s) |
2008-01 | Quality of life and survival in the 2 years after surgery for non-small cell lung cancer | Kenny, PM; King, MT; Viney, RC; Boyer, M; Pollicino, C; McLean, J; Fulham, MJ; McCaughn, B |
2008-01 | Quality of life and survival in the 2 years after surgery for non-small-cell lung cancer | Kenny, PM; King, MT; Viney, RC; Boyer, M; Pollicino, C; McLean, J; Fulham, MJ; McCaughan, BC |
2008-09 | Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. | Cocks, K; King, MT; Velikova, G; Fayers, PM; Brown, JM |
2004-12-01 | Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer | Viney, RC; Boyer, MJ; King, MT; Kenny, PM; Pollicino, CA; McLean, JM; McCaughan, BC; Fulham, MJ |
2012-12-01 | Repeatability of the six-minute walk test and relation to physical function in survivors of a critical illness | Alison, JA; Kenny, P; King, MT; Mckinley, S; Aitken, LM; Leslie, GD; Elliott, D |
2009-01 | The SF-36 walk-wheel: a simple modification of the SF-36 physical domain improves its responsiveness for measuring health status change in spinal cord injury. | Lee, BB; Simpson, JM; King, MT; Haran, MJ; Marial, O |
2004-08-01 | Staging lung cancer using positron emission tomography and the impact on care | Viney, RC; Boyer, MJ; King, MT; Spigel, DR |
2006-06-22 | Study protocol: Home-based physical rehabilitation for survivors of a critical illness [ACTRN12605000166673] | Elliott, D; McKinley, S; Alison, JA; Aitken, LM; King, MT |
2012-02-14 | Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer | King, MT; Viney, R; Smith, DP; Hossain, I; Street, D; Savage, E; Fowler, S; Berry, MP; Stockler, M; Cozzi, P; Stricker, P; Ward, J; Armstrong, BK |
2022-06-16 | The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study. | McTaggart-Cowan, H; King, MT; Norman, R; Costa, DSJ; Pickard, AS; Viney, R; Peacock, SJ; Canadian MAUCa Team, |
2021-06-01 | The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set | King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Muller, F; Viney, R; Pickard, AS; Cella, D |
2021-06 | The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. | King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Müller, F; Viney, R; Pickard, AS; Cella, D; Multi-Attribute Utility in Cancer Consortium, |
2011-01-01 | Time trade-off derived EQ-5D weights for Australia | Viney, R; Norman, R; King, MT; Cronin, P; Street, DJ; Knox, S; Ratcliffe, J |
2019 | U.K. utility weights for the EORTC QLU‐C10D | Norman, R; Mercieca-Bebber, R; Rowen, D; Brazier, JE; Cella, D; Pickard, AS; Street, DJ; Viney, R; King, MT |
2021-05 | United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument. | Revicki, DA; King, MT; Viney, R; Pickard, AS; Mercieca-Bebber, R; Shaw, JW; Müller, F; Norman, R |
2024-01 | United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument. | King, MT; Revicki, DA; Norman, R; Müller, F; Viney, RC; Pickard, AS; Cella, D; Shaw, JW; MAUCa Consortium, |
2016-03-01 | Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format | Norman, R; Viney, R; Aaronson, NK; Brazier, JE; Cella, D; Costa, DSJ; Fayers, PM; Kemmler, G; Peacock, S; Pickard, AS; Rowen, D; Street, DJ; Velikova, G; Young, TA; King, MT |
2009-06 | Validation and calibration of the SF-36 health transition question against an external criterion of clinical change in health status. | Knox, SA; King, MT |
2009-03-01 | Validation of modified forms of the PedsQL generic core scales and cancer module scales for adolescents and young adults (AYA) with cancer or a blood disorder | Ewing, JE; King, MT; Smith, NF |
2008-07 | Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population. | Lee, BB; King, MT; Simpson, JM; Haran, MJ; Stockler, MR; Marial, O; Salkeld, G |